相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study
Frances Rees et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Managing gout needs more than drugs: 'Il faut le savoir-faire, l'Art et la maniere'
Frederic Liote et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Clinically Insignificant Effect of Supplemental Vitamin C on Serum Urate in Patients With Gout: A Pilot Randomized Controlled Trial
Lisa K. Stamp et al.
ARTHRITIS AND RHEUMATISM (2013)
Metabolic syndrome, diabetes, and hyperuricemia
Changgui Li et al.
CURRENT OPINION IN RHEUMATOLOGY (2013)
HLA- B*5801: utility and cost- effectiveness in the Asia- Pacific Region
Siaw Ing Yeo
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2013)
Independent and conjoint associations of gout and hyperuricaemia with total and cardiovascular mortality
A. G. Stack et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2013)
Risk of myocardial infarction among patients with gout: a nationwide population-based study
Chang-Fu Kuo et al.
RHEUMATOLOGY (2013)
Gout and its comorbidities: implications for therapy
Lisa K. Stamp et al.
RHEUMATOLOGY (2013)
Primary care providers' knowledge, beliefs and treatment practices for gout: results of a physician questionnaire
Leslie R. Harrold et al.
RHEUMATOLOGY (2013)
Severe Cutaneous Reactions Requiring Hospitalization in Allopurinol Initiators: A Population-Based Cohort Study
Seoyoung C. Kim et al.
ARTHRITIS CARE & RESEARCH (2013)
Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts
Tom M. Palmer et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Initiation of Allopurinol at First Medical Contact for Acute Attacks of Gout: A Randomized Clinical Trial
Thomas H. Taylor et al.
AMERICAN JOURNAL OF MEDICINE (2012)
Diagnosis of gout in patients with asymptomatic hyperuricaemia: a pilot ultrasound study
Eugenio De Miguel et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions
Naomi Schlesinger et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: a proof-of-concept randomised controlled trial
Nicola Dalbeth et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Dual energy CT in gout: a prospective validation study
Hyon K. Choi et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Patient and provider barriers to effective management of gout in general practice: a qualitative study
Karen Spencer et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Gout: why is this curable disease so seldom cured?
Michael Doherty et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Cherry Consumption and Decreased Risk of Recurrent Gout Attacks
Yuqing Zhang et al.
ARTHRITIS AND RHEUMATISM (2012)
Rilonacept (interleukin-1 trap) in the prevention of acute gout flares during initiation of urate-lowering therapy: Results of a phase II randomized, double-blind, placebo-controlled trial
H. Ralph Schumacher et al.
ARTHRITIS AND RHEUMATISM (2012)
Are either or both hyperuricemia and xanthine oxidase directly toxic to the vasculature?: A critical appraisal
Tuhina Neogi et al.
ARTHRITIS AND RHEUMATISM (2012)
Starting dose is a risk factor for allopurinol hypersensitivity syndrome: A proposed safe starting dose of allopurinol
Lisa K. Stamp et al.
ARTHRITIS AND RHEUMATISM (2012)
Patients' knowledge and beliefs concerning gout and its treatment: a population based study
Leslie R. Harrold et al.
BMC MUSCULOSKELETAL DISORDERS (2012)
Uric Acid, Hypertension, and Chronic Kidney Disease Among Alaska Eskimos: The Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) Study
Stacey E. Jolly et al.
JOURNAL OF CLINICAL HYPERTENSION (2012)
Serum Uric Acid and Adiposity: Deciphering Causality Using a Bidirectional Mendelian Randomization Approach
Tanica Lyngdoh et al.
PLOS ONE (2012)
Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid-lowering therapy: Results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study
H. Ralph Schumacher et al.
ARTHRITIS CARE & RESEARCH (2012)
2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis
Dinesh Khanna et al.
ARTHRITIS CARE & RESEARCH (2012)
2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia
Dinesh Khanna et al.
ARTHRITIS CARE & RESEARCH (2012)
High plasma uric acid concentration: causes and consequences
Erick Prado de Oliveira et al.
DIABETOLOGY & METABOLIC SYNDROME (2012)
Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study
Hyon K. Choi et al.
BRITISH MEDICAL JOURNAL (2012)
Novel Evidence-Based Colchicine Dose-Reduction Algorithm to Predict and Prevent Colchicine Toxicity in the Presence of Cytochrome P450 3A4/P-Glycoprotein Inhibitors
Robert A. Terkeltaub et al.
ARTHRITIS AND RHEUMATISM (2011)
A two-stage approach to the treatment of hyperuricemia in gout: The Dirty Dish hypothesis
Fernando Perez-Ruiz et al.
ARTHRITIS AND RHEUMATISM (2011)
Using Allopurinol Above the Dose Based on Creatinine Clearance Is Effective and Safe in Patients With Chronic Gout, Including Those With Renal Impairment
Lisa K. Stamp et al.
ARTHRITIS AND RHEUMATISM (2011)
Prevalence of Gout and Hyperuricemia in the US General Population The National Health and Nutrition Examination Survey 2007-2008
Yanyan Zhu et al.
ARTHRITIS AND RHEUMATISM (2011)
A new perspective on the pharmacoeconomics of colchicine
Albert I. Wertheimer et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
The Challenges of Gout Management in the Elderly
Lisa K. Stamp et al.
DRUGS & AGING (2011)
Acute gout management during hospitalization: a need for a protocol
S. R. Gnanenthiran et al.
INTERNAL MEDICINE JOURNAL (2011)
Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
The Experience and Impact of Living With Gout A Study of Men With Chronic Gout Using a Qualitative Grounded Theory Approach
Karen Lindsay et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2011)
Safety and Efficacy of Febuxostat Treatment in Subjects with Gout and Severe Allopurinol Adverse Reactions
Saima Chohan
JOURNAL OF RHEUMATOLOGY (2011)
Hyperuricemia and Incident Hypertension: A Systematic Review and Meta-Analysis
Peter C. Grayson et al.
ARTHRITIS CARE & RESEARCH (2011)
Effect of Oral Vitamin C Supplementation on Serum Uric Acid: A Meta-Analysis of Randomized Controlled Trials
Stephen P. Juraschek et al.
ARTHRITIS CARE & RESEARCH (2011)
Illness Perceptions in Patients With Gout and the Relationship With Progression of Musculoskeletal Disability
Nicola Dalbeth et al.
ARTHRITIS CARE & RESEARCH (2011)
Independent association of serum retinol and β-carotene levels with hyperuricemia: A national population study
Woo-Joo Choi et al.
ARTHRITIS CARE & RESEARCH (2011)
Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat Gouty Arthritis by suppressing inflammation: results of a randomized, dose-ranging study
Naomi Schlesinger et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Joint and tendon subclinical involvement suggestive of gouty arthritis in asymptomatic hyperuricemia: an ultrasound controlled study
Carlos Pineda et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Identification of dairy fractions with anti-inflammatory properties in models of acute gout
Nicola Dalbeth et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
High Versus Low Dosing of Oral Colchicine for Early Acute Gout Flare Twenty-Four-Hour Outcome of the First Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Comparison Colchicine Study
Robert A. Terkeltaub et al.
ARTHRITIS AND RHEUMATISM (2010)
Canakinumab for the Treatment of Acute Flares in Difficult-to-Treat Gouty Arthritis Results of a Multicenter, Phase II, Dose-Ranging Study
Alexander So et al.
ARTHRITIS AND RHEUMATISM (2010)
Engagement of Fatty Acids With Toll-like Receptor 2 Drives Interleukin-1β Production via the ASC/Caspase 1 Pathway in Monosodium Urate Monohydrate Crystal-Induced Gouty Arthritis
Leo A. B. Joosten et al.
ARTHRITIS AND RHEUMATISM (2010)
Serum uric acid levels predict the severity and morphology of coronary atherosclerosis detected by multidetector computed tomography
Ergun Baris Kaya et al.
ATHEROSCLEROSIS (2010)
Uric Acid-Lowering Treatment With Benzbromarone in Patients With Heart Failure A Double-Blind Placebo-Controlled Crossover Preliminary Study
Kazuhide Ogino et al.
CIRCULATION-HEART FAILURE (2010)
Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk
Marian Goicoechea et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Effect of Prophylaxis on Gout Flares After the Initiation of Urate-Lowering Therapy: Analysis of Data From Three Phase III Trials
Robert L. Wortmann et al.
CLINICAL THERAPEUTICS (2010)
Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial
Awsan Noman et al.
LANCET (2010)
Prescription and comorbidity screening following consultation for acute gout in primary care
Edward Roddy et al.
RHEUMATOLOGY (2010)
Anakinra's Efficacy is Variable in Refractory Gout: Report of Ten Cases
Kun Chen et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2010)
The urate-lowering Efficacy and Safety of Febuxostat in the Treatment Hyperuricemia of Gout: The CONFIRMS trial
C. Dejaco et al.
JOURNAL FUR MINERALSTOFFWECHSEL (2010)
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
Michael A. Becker et al.
ARTHRITIS RESEARCH & THERAPY (2010)
A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300-600 mg/day versus benzbromarone 100-200 mg/day in patients with gout
M. K. Reinders et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol
M. K. Reinders et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study
R. Terkeltaub et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Joint aspiration and injection and synovial fluid analysis
Philip Courtney et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2009)
Oral prednisolone is more cost-effective than oral indomethacin for treating patients with acute gout-like arthritis
Giles N. Cattermole et al.
EUROPEAN JOURNAL OF EMERGENCY MEDICINE (2009)
A single dose of rasburicase in elderly patients with hyperuricaemia reduces serum uric acid levels and improves renal function
Mariano Malaguarnera et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417 734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)
I. Holme et al.
JOURNAL OF INTERNAL MEDICINE (2009)
Treating to target: a strategy to cure gout
Fernando Perez-Ruiz
RHEUMATOLOGY (2009)
Colchicine Update: 2008
Robert A. Terkeltaub
SEMINARS IN ARTHRITIS AND RHEUMATISM (2009)
Efficacy and Safety of Losartan in Treatment of Hyperuricemia and Posttransplantation Erythrocytosis: Results of a Prospective, Open, Randomized, Case-Control Study
X. Zhu et al.
TRANSPLANTATION PROCEEDINGS (2009)
Effects of Febuxostat Versus Allopurinol and Placebo in Reducing Serum Urate in Subjects With Hyperuricemia and Gout: A 28-Week, Phase III, Randomized, Double-Blind, Parallel-Group Trial
H. Ralph Schumacher et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Comparison of serum uric acid levels between Japanese with and without metabolic syndrome
Takeyuki Numata et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
A benefit-risk assessment of benzbromarone in the treatment of gout - Was its withdrawal from the market in the best interest of patients?
Ming-Han H. Lee et al.
DRUG SAFETY (2008)
Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial
Hein J. E. M. Janssens et al.
LANCET (2008)
Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study
Hyon K. Choi et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations
Edward Roddy et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Are joints affected by gout also affected by osteoarthritis?
Edward Roddy et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Biochemical effectiveness of allopurinol and allopurinol-probenecid in previously benzbromarone-treated gout patients
Mattheus K. Reinders et al.
CLINICAL RHEUMATOLOGY (2007)
British Society for Rheumatology and British Health Professionals in rheumatology guideline for the management of gout
Kelsey M. Jordan et al.
RHEUMATOLOGY (2007)
Risk of myocardial infarction associated with selective COX-2 inhibitors: Meta-analysis of randomised controlled trials
Li-Chia Chen et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Comparison of oral prednisolone/paracetamol and oral indomethacin/paracetamol combination therapy in the treatment of acute goutlike arthritis: A double-blind, randomized, controlled trial
Chi Yin Man et al.
ANNALS OF EMERGENCY MEDICINE (2007)
A pilot study of IL-1 inhibition by anakinra in acute gout
Alexander So et al.
ARTHRITIS RESEARCH & THERAPY (2007)
EULAR evidence based recommendations for gout.: Part II:: Management.: Report of a task force of the EULAR standing committee for international clinical studies including therapeutics (ESCISIT)
W. Zhang et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase
NJ Ganson et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Febuxostat compared with allopurinol in patients with hyperuricemia and gout
MA Becker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
A two year randomised controlled trial of intramuscular depot steroids in patients with established rheumatoid arthritis who have shown an incomplete response to disease modifying antirheumatic drugs
EH Choy et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD)
TR Mikuls et al.
RHEUMATOLOGY (2005)
Correction of allopurinol dosing should be based on clearance of creatinine, but not plasma creatinine levels - Another insight to allopurinol-related toxicity
F Perez-Ruiz et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2005)
The effects of vitamin C supplementation on serum concentrations of uric acid - Results of a randomized controlled trial
HY Huang et al.
ARTHRITIS AND RHEUMATISM (2005)
Obesity, weight change, hypertension, diuretic use, and risk of gout in men - The health professionals follow-up study
HK Choi et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Febuxostat, a Novel Nonpurine Selective Inhibitor of Xanthine Oxidase
Michael A. Becker et al.
ARTHRITIS AND RHEUMATISM (2005)
Gout epidemiology: results from the UK general practice research database, 1990-1999
TR Mikuls et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Alcohol intake and risk of incident gout in men: a prospective study
HK Choi et al.
LANCET (2004)
Purine-rich foods, dairy and protein intake, and the risk of gout in men
HK Choi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout -: A randomized controlled trial
BR Rubin et al.
ARTHRITIS AND RHEUMATISM (2004)
Adverse renal effects of anti-inflammatory agents: evaluation of selective and nonselective cyclooxygenase inhibitors
G Gambaro et al.
JOURNAL OF INTERNAL MEDICINE (2003)
Anti-inflammatory agents and renal function
DC Brater
SEMINARS IN ARTHRITIS AND RHEUMATISM (2002)
Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout
F Perez-Ruiz et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2002)
Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis
HR Schumacher et al.
BMJ-BRITISH MEDICAL JOURNAL (2002)
Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure - Results from 2 placebo-controlled studies
W Doehner et al.
CIRCULATION (2002)
Relation between adverse events associated with allopurinol and renal function in patients with gout
J Vázquez-Mellado et al.
ANNALS OF THE RHEUMATIC DISEASES (2001)
分享论文
